Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema

References

• HarrisMIDiabetes in America: epidemiology and scope of the problemDiabetes Care199821Suppl 3C11C149850480
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSEDavisMDDeMetsDLThe Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more yearsArch Ophthalmol19841025275326367725
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEKMossSEDavisMDDeMetsDLThe Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 yearsArch Ophthalmol19841025205266367724
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupEarly photocoagulation for diabetic retinopathy. ETDRS Report 9Ophthalmology199198Suppl7667852062512
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupPhotocoagulation for diabetic macular edemaArch Ophthalmol1985103179618062866759
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupFocal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report 19Arch Ophthalmol1995113114411557661748
   PubMed Web of Science ®Google Scholar
• MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care2010332399240520980427
   PubMed Web of Science ®Google Scholar
• HaritoglouCKookDNeubauerAIntravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edemaRetina200626999100517151486
   PubMed Web of Science ®Google Scholar
• NguyenQDBrownDMMarcusDMet al;RISERIDE Research GroupRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology201211978980122330964
   PubMed Web of Science ®Google Scholar
• FramptonJERanibizumab: in diabetic macular oedemaDrugs20127250952322356289
   PubMed Web of Science ®Google Scholar
• AudrenFLecleire-ColletAErginayAIntravitreal triamcinolone acetonide for diffuse diabetic macular edema: Phase 2 trial comparing 4 mg vs 2 mgAm J Ophthalmol200614279479916978576
   PubMed Web of Science ®Google Scholar
• La HeijECLundqvistIJBerendschotTTHardyELiemATHendrikseFIntravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure riseAm J Ophthalmol200714317617817188065
   PubMed Web of Science ®Google Scholar
• GibranSKCullinaneAJungkimSClearyPEIntravitreal triamcinolone for diffuse diabetic macular oedemaEye20062072072416021193
   PubMed Web of Science ®Google Scholar
• JoussenAMPoulakiVLeMLA central role for inflammation in the pathogenesis of diabetic retinopathyFASEB J2004181450145215231732
   PubMed Web of Science ®Google Scholar
• KleinmanMEBaffJZAmbatiJThe multifactorial nature of retinal vascular diseaseOphthalmologica2010224Suppl 1162420714177
   PubMed Web of Science ®Google Scholar
• BrownleeMGlycation and diabetic complicationsDiabetes1994438368418194672
   PubMed Web of Science ®Google Scholar
• FrankRNOn the pathogenesis of diabetic retinopathyOphthalmology1984916266346205341
   PubMed Web of Science ®Google Scholar
• VinoresSAVan NielESwerdloffJLCampochiaroPAElectron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibitionExp Eye Res1993577237358150024
   PubMed Web of Science ®Google Scholar
• AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol19941184454507943121
   PubMed Web of Science ®Google Scholar
• BhagatNGrigorianRATutelaAZarbinMADiabetic macular edema: pathogenesis and treatmentSurv Ophthalmol20095413219171208
   PubMed Web of Science ®Google Scholar
• IshidaSUsuiTYamashiroKVEGF164 is proinflammatory in the diabetic retinaInvest Ophthalmol Vis Sci2003442155216212714656
   PubMed Web of Science ®Google Scholar
• DuXMatsumuraTEdelsteinDInhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cellsJ Clin Invest20031121049105714523042
   PubMed Web of Science ®Google Scholar
• BrownleeMBiochemistry and molecular cell biology of diabetic complicationsNature200141481382011742414
   PubMed Web of Science ®Google Scholar
• BringmannAWiedemannPMüller glial cells in retinal diseaseOphthalmologica201222711921921569
   PubMed Web of Science ®Google Scholar
• TamuraHMiyamotoKKiryuJIntravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retinaInvest Ophthalmol Vis Sci2005461440144415790913
   PubMed Web of Science ®Google Scholar
• MiyamotoKHiroshibaNTsujikawaAOguraYIn vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic ratsInvest Ophthalmol Vis Sci199839219021949761301
   PubMed Web of Science ®Google Scholar
• EdelmanJLDifferentiating intraocular glucocorticoidsOphthalmologica2010224Suppl 1253020714178
   PubMed Web of Science ®Google Scholar
• KiernanDFMielerWFThe use of intraocular corticosteroidsExpert Opin Pharmacother2009102511252519761356
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study Research GroupTreatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2Ophthalmology1987947617743658348
   PubMed Web of Science ®Google Scholar
• BrowningDJAltaweelMMBresslerNMBresslerSBScottIUDiabetic Retinopathy Clinical Research NetworkDiabetic macular edema: what is focal and what is diffuse?Am J Ophthalmol200814664965518774122
   PubMedGoogle Scholar
• LeeCMOlkRJModified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual resultsOphthalmology199198159416021961650
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMGastonCFive-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edemaOphthalmology20091162182218719796823
   PubMed Web of Science ®Google Scholar
• JonasJBDegenringRFKreissigIAkkoyunIKamppeterBAIntraocular pressure elevation after intravitreal triamcinolone acetonide injectionOphthalmology200511259359815808249
   PubMed Web of Science ®Google Scholar
• ZucchiattiILattanzioRQuerquesGIntravitreal dexamethasone implant in patients with persistent diabetic macular edemaOphthalmologica201222811712222310491
   PubMed Web of Science ®Google Scholar
• HallerJAKuppermannBDBlumenkranzMSet al; Dexamethasone DDS Phase II Study Group. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edemaArch Ophthalmol201012828929620212197
   PubMed Web of Science ®Google Scholar
• JonasJBSpandauUHKamppeterBAVossmerbaeumerUHarderBSauderGRepeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edemaOphthalmology200611380080416530840
   PubMed Web of Science ®Google Scholar
• HauserDBukelmanAPokroyRIntravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mgRetina20082882583018536598
   PubMed Web of Science ®Google Scholar
• CampochiaroPAHafizGShahSMFAMOUS Study GroupSustained ocular delivery of fluocinolone acetonide by an intravitreal insertOphthalmology20101171393139920202684
   PubMed Web of Science ®Google Scholar
• CampochiaroPANguyenQDHafizGFAMOUS Study GroupAqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsOphthalmology1242012 [Epub ahead of print.]
   Google Scholar
• CampochiaroPABrownDMPearson A, et al; FAME Study Group. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaOphthalmology20121192125213222727177
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMPearson A, et al; FAME Study Group. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edemaOphthalmology201111862663521459216
   PubMed Web of Science ®Google Scholar
• PearsonPAComstockTLIpMFluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trialOphthalmology20111181580158721813090
   PubMed Web of Science ®Google Scholar
• ElmanMJAielloLPBeckRWDiabetic Retinopathy Clinical Research NetworkRandomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology20101171064107720427088
   PubMed Web of Science ®Google Scholar
• ElmanMJQinHAielloLPDiabetic Retinopathy Clinical Research NetworkIntravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial resultsOphthalmology20121192312231822999634
   PubMed Web of Science ®Google Scholar